Əsas səhifə

Çap

Əks əlaqə

İnfo
Decompressive surgery for treating nerve damage in leprosy

Mündəricat

Decompressive surgery for treating nerve damage in leprosy

Sübutlu məlumatların xülasələri
16.04.2015 • Sonuncu dəyişiklik 16.04.2015
Editors

Decompression surgery as add-on treatment to oral prednisolone might possibly not be beneficial in the treatment of nerve damage in leprosy, but the evidence is insufficient.

A Cochrane review included 2 studies with a total of 88 subjects. Both tested decompression surgery plus oral corticosteroids versus oral corticosteroids alone. The interventions and outcomes were too heterogeneous to be combined in a meta-analysis. After two years follow-up there was no significant difference in nerve function improvement between people treated with surgery plus prednisolone or with prednisolone alone. Adverse effects of decompressive surgery were not adequately described.

Comment: The quality of evidence is downgraded by imprecise results (few patients and wide confidence intervals), by inconsistency (heterogeneity in interventions and outcomes), and by study quality (more than 20% loss to follow up).

Ədəbiyyat

  1. Van Veen NH, Schreuders TA, Theuvenet WJ, Agrawal A, Richardus JH. Decompressive surgery for treating nerve damage in leprosy. Cochrane Database Syst Rev 2009 Jan 21;(1):CD006983 [Review content assessed as up-to-date: 3 August 2010].
  2. Van Veen NH, Schreuders TA, Theuvenet WJ et al. Decompressive surgery for treating nerve damage in leprosy. Cochrane Database Syst Rev 2012;12():CD006983. .